Moderna's Phase 2, $90 Target Inevitable

First off, please don't take anything I say seriously or as financial advice. As always, this is on opinion based basis. Moderna's Covid19 vaccine for mRNA-1273 is reaching Phase 2 clinical trails by the FDA which is further ahead than most of its small competitors and bio-pharmaceutical corporations. As always, you see the big giant crushing the small one. This news is expected to have a surge in buy signals and once it passes the $70 threshold quite soon, it will lead to a $90 short being the next actual target. That's right it can go that high, and who would be surprised?